Undertreatment of Neutropenia

Patients younger than 65 years who have non-Hodgkin lymphoma (NHL) are less likely to receive prophylactic treatment for grade 3 and 4 neutropenia.

In a study in which 1,570 patients with NHL were enrolled, it was found that there were disparities in the way granulocyte colony-stimulating factor (G-CSF) was administered. While all patients received CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone), those in the younger age group (65 years and under, 54%) were less likely to receive G-CSF with their chemotherapy as a preventive measure than those in the older age group (65 years and older, 45.9%). For more information, click here.


Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe


Have you ever attended a meeting with a lymphoma support group?




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 03/27/18. Copyright © 2018 Lymphoma Coalition. All rights reserved.